Women more likely to experience severe toxicity from cancer treatment

Women receiving cancer treatment in clinical trials exhibited higher risk for severe symptomatic and hematologic adverse events than their male counterparts, according to a study.These findings remained consistent across multiple treatment modalities, including immunotherapy, chemotherapy and target...